Novacyt (LON:NCYT)
49.90p+1.84%
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Trading below net cash, this diagnostics firm faces dilution risk as its twelve-month runway tests unproven growth plans.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Novacyt
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer De…
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- £35.1M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Novacyt and 1,600+ UK and US stocks.
Start free